Results from pre-clinical research show iron-like compound hold promise for treating patients with glioblastoma, an aggressive brain cancer
If approved, it will be the first USFDA-approved immunomodulator for the treatment of Covid-19 in hospitalised patients
This state-of-art technology will help pulmonologists to diagnose lung cancer in the very early stages helping the patient get an early surgical resection
It paves the way for an industry Code of Good Practice
Companies to leverage proprietary IgM antibody technology platform to discover agonists against three oncology targets and three immunology/inflammation targets
The science leader comes with a rich experience in the employment testing industry
50 µg dose approved for all adults over 50 years of age and immunocompromised adults over 18 years of age
Clinical trials for minimally invasive therapy procedures using advanced imaging from Philips Lung Suite start with successful first cases
The company’s differentiated value proposition comes during a time of unprecedented disruption in the life science supply chain
Additional data across neurological disorders, including Alzheimer’s disease, help advance the scientific understanding of these conditions and the potential impact of early treatment
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
